Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety
NCT05139121Phase 3Completed
- Sponsor
- Viatris
- Start
- Oct 2021
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of ethinyl estradiol + norelgestromin in contraception, sponsored by Viatris. Started Oct 2021; status: completed.
02
Drugs
ethinyl estradiol + norelgestromin
03
Conditions
contraception
Beyond the preview
Go deeper on NCT05139121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05139121.